National Health Spending Expected to Increase Through 2028
National health expenditures expected to represent 19.7 percent of gross domestic product by 2028
FDA Warns of Defective EpiPen Dangers
Devices may activate prematurely if the blue safety release is removed using sideways force
Daily Low-Dose Aspirin Does Not Cut Dementia Risk in Seniors
Risks for dementia, probable Alzheimer disease, MCI not reduced by low-dose aspirin versus placebo
IDSA Issues Recommendations for COVID-19 Testing
Four-tier approach prioritizes ICU patients, those with symptoms and contact with a patient or travel history
Interleukin-1β Inhibition Linked to Reduced Incidence of Anemia
Among those with baseline anemia, hemoglobin levels improved with canakinumab versus placebo
Shortages Seen for Drugs That Show Promise Against COVID-19
Patients who currently rely on remdesivir or hydroxychloroquine now facing dangerous shortages
FDA: Insulin Among Drugs Transitioned to Biological Products
New regulatory pathway for biologic drugs allows for approval of biosimilars, interchangeable versions
Triple Therapy Cuts Mortality in Patients With Symptomatic COPD
All-cause mortality risk significantly lower for triple-drug regimen versus one of two dual-drug regimens
Cumulative Dose of Oral Steroids Associated With HTN Incidence
Incidence of hypertension higher for adults on oral steroids for any of six chronic inflammatory diseases
CDC: Modest Decreases Seen in TB Cases, TB-Related Deaths
From 2017 to 2018, 2 and 5 percent declines seen in incident TB and TB-related deaths, respectively
